Nuclear factor κB down-regulates human UDP-glucuronosyltransferase 1A1: A novel mechanism involved in inflammation-associated hyperbilirubinaemia

Tzu-Yue Shiu, Tien-Yu Huang, Shih-Ming Huang, Yu-Lueng Shih, Heng-Cheng Chu, Wei-Kuo Chang, Tsai-Yuan Hsieh

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Jaundice or hyperbilirubinaemia is a common complication of sepsis. UGT1A1 (UDP-glucuronosyltransferase 1A1) is a critical gene for bilirubin metabolism and irinotecan detoxification. However, the molecular pathogenesis of hyperbilirubinaemia during inflammation needs to be further clarified. Human hepatic UGT1A1 expression was analysed by RT (reverse transcription)-PCR, qRT-PCR (quantitative real-time PCR) and Western blotting in response to LPS (lipopolysaccharide) stimulation. Transcription regulatory elements in the upstream promoter region of the human UGT1A1 gene were determined using EMSA (electrophoretic mobility-shift assay) and ChIP (chromatin immunoprecipitation). The important role of the transcription regulatory element was examined using a luciferase assay, and was determined by qRT-PCR using a transcription factor activation inhibitor. LPS down-regulated the UGT1A1 mRNA expression in human hepatoma cell lines. A newly identified NF-κB (nuclear factor κB)-binding site was located on the upstream promoter region (-725/-716) of the human UGT1A1 gene. LPS-induced NF-κB activation and specific binding to the NF-κB-binding site can suppress human UGT1A1 promoter activity and human UGT1A1 expression. We demonstrated that LPS mediates the suppression of human UGT1A1 expression through specific binding of NF-κB to this newly identified NF-κB-binding site in the upstream promoter of the human UGT1A1 gene. The present study may partly explain the molecular pathogenesis of inflammation-associated hyperbilirubinaemia. © The Authors Journal compilation © 2013 Biochemical Society.
Original languageEnglish
Pages (from-to)761-770
Number of pages10
JournalBiochemical Journal
Volume449
Issue number3
DOIs
Publication statusPublished - 2013
Externally publishedYes

Keywords

  • Hyperbilirubinaemia
  • Inhibitor
  • Lipopolysaccharide (LPS)
  • Nuclear factor κB (NF-κB)
  • Promoter
  • UDP-glucuronosyltransferase 1A1 (UGT1A1)
  • glucuronosyltransferase 1A1
  • immunoglobulin enhancer binding protein
  • lipopolysaccharide
  • animal experiment
  • article
  • binding site
  • cancer cell culture
  • chromatin immunoprecipitation
  • controlled study
  • disease association
  • down regulation
  • enzyme activation
  • gel mobility shift assay
  • human
  • human cell
  • hyperbilirubinemia
  • inflammation
  • mouse
  • nonhuman
  • pathogenesis
  • priority journal
  • protein expression
  • real time polymerase chain reaction
  • reverse transcription polymerase chain reaction
  • Western blotting
  • Animals
  • Base Sequence
  • Binding Sites
  • Cell Line
  • DNA, Complementary
  • Down-Regulation
  • Glucuronosyltransferase
  • Hep G2 Cells
  • Humans
  • Hyperbilirubinemia
  • Inflammation
  • Lipopolysaccharides
  • Liver
  • Mice
  • Mice, Inbred C57BL
  • Models, Biological
  • NF-kappa B
  • Promoter Regions, Genetic
  • RNA, Messenger

Fingerprint Dive into the research topics of 'Nuclear factor κB down-regulates human UDP-glucuronosyltransferase 1A1: A novel mechanism involved in inflammation-associated hyperbilirubinaemia'. Together they form a unique fingerprint.

  • Cite this